参考文献/References:
[1] Paulini J,Higuti E,Bastos RM,et al.Mesenchymal stem cells as therapeutic candidates for halting the progression of diabetic nephropathy[J].Stem Cells Int,2016,2016:9521629.DOI:10.1155/2016/9521629.
[2] Maezawa Y,Takemoto M,Yokote K.Cell biology of diabetic nephropathy: roles of endothelial cells, tubulointerstitial cells and podocytes[J].J Diabetes Investig,2015,6(1):3-15.DOI:10.1111/jdi.12255.
[3] Sagoo MK,Gnudi L.Diabetic nephropathy:is there a role for oxidative stress?[J].Free Radic Biol Med,2018,116:50-63.DOI:10.1016/j.freeradbiomed.2017.12.040.
[4] Berebichez-Fridman R,Montero-Olvera PR.Sources and clinical applications of mesenchymal stem cells: state-of-the-art review[J].Sultan Qaboos Univ Med J,2018,18(3):e264-e277.DOI:10.18295/squmj.2018.18.03.002.
[5] Pal B,Das B.In vitro culture of naïve human bone marrow mesenchymal stem cells:a stemness based approach[J].Front Cell Dev Biol,2017,5:69.DOI:10.3389/fcell.2017.00069.
[6] Melief SM,Zwaginga JJ,Fibbe WE,et al.Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts[J].Stem Cells Transl Med,2013,2(6):455-463.DOI:10.5966/sctm.2012-0184.
[7] Ding DC,Chang YH,Shyu WC,et al.Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy[J].Cell Transplant,2015,24(3):339-347.DOI:10.3727/096368915X686841.
[8] Zheng Z,Zheng F.Immune cells and inflammation in diabetic nephropathy[J].J Diabetes Res,2016,2016:1841690.DOI:10.1155/2016/1841690.
[9] Lin T,Pajarinen J,Nabeshima A,et al.Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis[J].Stem Cell Res Ther,2017,8(1):277.DOI:10.1186/s13287-017-0730-z.
[10] Dong L,Chen X,Shao H,et al.Mesenchymal stem cells inhibited dendritic cells via the regulation of STAT1 and STAT6 phosphorylation in experimental autoimmune uveitis[J].Curr Mol Med,2018,17(7):478-487.DOI:10.2174/1566524018666180207155614.
[11] Cao W,Cao K,Cao J,et al.Mesenchymal stem cells and adaptive immune responses[J].Immunol Lett,2015,168(2):147-153.DOI:10.1016/j.imlet.2015.06.003.
[12] Sierra-Mondragon E,Molina-Jijon E,Namorado-Tonix C,et al.All-trans retinoic acid ameliorates inflammatory response mediated by TLR4/NF-κB during initiation of diabetic nephropathy[J].J Nutr Biochem,2018,60:47-60.DOI:10.1016/j.jnutbio.2018.06.002.
[13] Li D,Zhang D,Tang B,et al.Exosomes from human umbilical cord mesenchymal stem cells reduce damage from oxidative stress and the epithelial-mesenchymal transition in renal epithelial cells exposed to oxalate and calcium oxalate monohydrate[J].Stem Cells Int,2019,2019:6935806.DOI:10.1155/2019/6935806.
[14] Hamza AH,Al-Bishri WM,Damiati LA,et al.Mesenchymal stem cells:a future experimental exploration for recession of diabetic nephropathy[J].Ren Fail,2017,39(1):67-76.DOI:10.1080/0886022X.2016.1244080.
[15] 郎宏,戴春.骨髓间充质干细胞对糖尿病大鼠肾脏基质金属蛋白酶-9表达及纤维化的影响[J].中华实验外科杂志,2016,33(2):447-452.DOI: 10.3760/cma.j.issn.1001-9030.2016.02.050.
[16] Nagaishi K,Mizue Y,Chikenji T,et al.Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes[J].Sci Rep,2016,6:34842.DOI:10.1038/srep34842.
[17] Tomasoni S,Longaretti L,Rota C,et al.Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells[J].Stem Cells Dev,2013,22(5):772-780.DOI:10.1089/scd.2012.0266.
[18] Lv S,Cheng J,Sun A,et al.Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress[J].Diabetes Res Clin Pract,2014,104(1):143-154.DOI:10.1016/j.diabres.2014.01.011.
[19] Lv S,Liu G,Sun A,et al.Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7[J].Diab Vasc Dis Res,2014,11(4):251-261. DOI:10.1177/1479164114531300.
[20] Li D,Wang N,Zhang L,et al.Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor[J].Stem Cell Res Ther,2013,4(5):103.DOI:10.1186/scrt314.
[21] Wen H,Kumar V,Mishra A,et al.Grem2 mediates podocyte apoptosis in high glucose milieu[J].Biochimie,2019,160:113-121.DOI:10.1016/j.biochi.2019.02.015.
[22] Zou X,Gu D,Xing X,et al.Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats[J].Am J Transl Res,2016,8(10):4289-4299.
[23] Lv SS,Liu G,Wang JP,et al.Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration[J].Int Immunopharmacol,2013,17(2):275-282.DOI:10.1016/j.intimp.2013.05.031.
[24] Loeffler I,Wolf G.Transforming growth factor-β and the progression of renal disease[J].Nephrol Dial Transplant,2014,29(Suppl 1):i37-i45.DOI:10.1093/ndt/gft267.
[25] Chung JK,Park SA,Hwang HS,et al.Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis[J].Int J Ophthalmol,2017,10(3):329-335.DOI:10.18240/ijo.2017.03.01.
[26] Aghajani Nargesi A,Lerman LO,Eirin A.Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges[J].Stem Cell Res Ther,2017,8(1):273.DOI:10.1186/s13287-017-0727-7.
[27] Keshtkar S,Azarpira N,Ghahremani MH.Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine[J].Stem Cell Res Ther,2018,9(1):63.DOI:10.1186/s13287-018-0791-7.
[28] Squillaro T,Peluso G,Galderisi U.Clinical trials with mesenchymal stem cells: an update[J].Cell Transplant,2016,25(5):829-848.DOI:10.3727/096368915X689622.
[29] Wu S,Li L,Wang G,et al.Ultrasound-targeted stromal cell-derived factor-1-loaded microbubble destruction promotes mesenchymal stem cell homing to kidneys in diabetic nephropathy rats[J].Int J Nanomedicine,2014,9:5639-5651.DOI:10.2147/IJN.S73950.
[30] Zhang L,Li K,Yan X,et al.MicroRNA-498 inhibition enhances the differentiation of human adipose-derived mesenchymal stem cells into podocyte-like cells[J].Stem Cells Dev,2015,24(24):2841-2852.DOI:10.1089/scd.2015.0027.
[31] Wong CY,Tan EL,Cheong SK.In vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells[J].Cell Biol Int,2014,38(4):497-501.DOI:10.1002/cbin.10231.
[32] Willkomm L,Bloch W.State of the art in cell-cell fusion[J].Methods Mol Biol,2015,1313:1-19.DOI:10.1007/978-1-4939-2703-6_1.
[33] Haneef K,Ali A,Khan I,et al.Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo[J].Cardiovasc Ther,2018,36(6):e12479.DOI:10.1111/1755-5922.12479.
[34] Sumi S,Yanai G.Fusion of mesenchymal stem cells and islet cells for cell therapy[J].Methods Mol Biol,2015,1313:107-113.DOI:10.1007/978-1-4939-2703-6_7.
[35] Betz B,Conway BR.An update on the use of animal models in diabetic nephropathy research[J].Curr Diab Rep,2016,16(2):18.DOI:10.1007/s11892-015-0706-2.
[36] Packham DK,Fraser IR,Kerr PG,et al.Allogeneic mesenchymal precursor cells(MPC)in diabetic nephropathy: a randomized, placebo-controlled, dose escalation study[J].EBioMedicine,2016,12:263-269.DOI:10.1016/j.ebiom.2016.09.011.
[37] 赵堂亮,吴正敏,谭建明,等.脐带间充质干细胞移植对糖尿病肾病的临床观察[J].中华细胞与干细胞杂志(电子版),2016,6(2):110-114.DOI:10.3877/cma.j.issn.2095-1221.2016.02.007.
相似文献/References:
[1]李雅,王志斌,刘玮晔,等.巨噬细胞与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
Li Ya*,Wang Zhibin,Liu Weiye,et al.Macrophages and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(06):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
[2]王丹,关美萍,薛耀明.早期生长反应因子-1与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):397.[doi:10.3760/cma.j.issn.1673-4157.2014.06.010]
Wang Dan,Guan Meiping,Xue Yaoming..Early growth response factor-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(06):397.[doi:10.3760/cma.j.issn.1673-4157.2014.06.010]
[3]翟丽敏,叶山东.二甲双胍的抗炎作用及其糖尿病肾脏保护作用[J].国际内分泌代谢杂志,2014,(05):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
Zhai Limin,Ye Shandong..Anti-inflammatory effects of metformin and its renal protection in diabetes[J].International Journal of Endocrinology and Metabolism,2014,(06):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
[4]玄先法,李清芹,王玉新,等.肾炎康复片联合缬沙坦治疗Ⅳ期糖尿病肾病蛋白尿的临床研究[J].国际内分泌代谢杂志,2014,(05):353.[doi:10.3760/cma.j.issn.1673-4157.2014.05.019]
Xuan Xianfa,Li Qingqin,Wang Yuxin,et al.Clinical study of Shenyankangfu tablet combined with valsartan capsule on proteinuria in patients with stage Ⅳ diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(06):353.[doi:10.3760/cma.j.issn.1673-4157.2014.05.019]
[5]曹萌 陈堃 茅晓东 刘超.限食治疗糖尿病肾病的研究进展[J].国际内分泌代谢杂志,2015,(06):395.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.009]
Cao Meng,Chen Kun,Mao Xiaodong,et al.Effects of diet restriction on diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(06):395.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.009]
[6]于菁 王秋月.多聚ADP核糖聚合酶-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(06):409.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.013]
Yu Jing,Wang Qiuyue..Poly(ADP-ribose)polymerase-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(06):409.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.013]
[7]马静茹,牟新.表观遗传学与糖尿病肾病[J].国际内分泌代谢杂志,2016,36(01):52.[doi:10.3760/cma.j.issn.1673-4157.2016.01.013]
Ma Jingru*,Mou Xin..Epigenetics and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):52.[doi:10.3760/cma.j.issn.1673-4157.2016.01.013]
[8]杨薇,李春君,孙蓓,等.雷公藤多苷对糖尿病肾病大鼠核因子-κB
信号通路的影响[J].国际内分泌代谢杂志,2016,36(02):107.[doi:10.3760/cma.j.issn.1673-4157.2016.02.008]
Yang Wei*,Li Chunjun,Sun Bei,et al.Effects of triperygium wilfordii polyglucoside on nuclear factor-κB signaling pathway in rats with diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):107.[doi:10.3760/cma.j.issn.1673-4157.2016.02.008]
[9]刘艳,田秀标,韩颖,等.血管紧张素1-7与糖尿病及糖尿病肾脏
内质网应激关系的研究[J].国际内分泌代谢杂志,2016,36(03):157.[doi:10.3760/cma.j.issn.1673-4157.2016.03.04]
Liu Yan*,Tian Xiubiao,Han Ying,et al.Relationship between angiotensin 1-7, diabetes and endoplasmic reticulum stress of diabetic kidney[J].International Journal of Endocrinology and Metabolism,2016,36(06):157.[doi:10.3760/cma.j.issn.1673-4157.2016.03.04]
[10]周宇,柯甦捷,刘礼斌.血尿酸与糖尿病肾病[J].国际内分泌代谢杂志,2016,36(03):202.[doi:10.3760/cma.j.issn.1673-4157.2016.03.15]
Zhou Yu,Ke Sujie,Liu Libin..Serum uric acid and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):202.[doi:10.3760/cma.j.issn.1673-4157.2016.03.15]